{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T22:25:27Z","timestamp":1789770327101,"version":"4.0.1"},"reference-count":51,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T00:00:00Z","timestamp":1773360000000},"content-version":"am","delay-in-days":346,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001059","name":"Connecticut Bar Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001059","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P30 CA008748"],"award-info":[{"award-number":["P30 CA008748"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004334","name":"Merck","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004334","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100030728","name":"Debiopharm","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100030728","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","redjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Radiation Oncology*Biology*Physics"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.ijrobp.2024.11.088","type":"journal-article","created":{"date-parts":[[2024,11,28]],"date-time":"2024-11-28T18:56:31Z","timestamp":1732820191000},"page":"1248-1257","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Consolidation Regimen and Cerebral Atrophy in Patients With Primary Central Nervous System Lymphoma"],"prefix":"10.1016","volume":"121","author":[{"given":"Kathryn R.","family":"Tringale","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Grommes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Burcin A.","family":"Ucpinar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne S.","family":"Reiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joachim","family":"Yahalom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gustav Y.","family":"Cederquist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren R.","family":"Schaff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vaios","family":"Hatzoglou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert J.","family":"Young","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mousa","family":"Payinkay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grace","family":"Bartlett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Scordo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brandon S.","family":"Imber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javin","family":"Schefflein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijrobp.2024.11.088_bib0001","doi-asserted-by":"crossref","first-page":"13","DOI":"10.21037\/aol-20-37","article-title":"Narrative review of primary central nervous system lymphoma: Treatment-related neurotoxicity","volume":"5","author":"Correa","year":"2021","journal-title":"Ann Lymphoma"},{"key":"10.1016\/j.ijrobp.2024.11.088_bib0002","doi-asserted-by":"crossref","first-page":"2410","DOI":"10.1200\/JCO.2017.72.7602","article-title":"Primary CNS Lymphoma","volume":"35","author":"Grommes","year":"2017","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2024.11.088_bib0003","doi-asserted-by":"crossref","first-page":"4483","DOI":"10.1200\/JCO.2003.03.108","article-title":"High-dose methotrexate-based chemotherapy followed by consolidating radiotherapy in non-AIDS-related primary central nervous system lymphoma: European Organization for Research and Treatment of Cancer Lymphoma Group Phase II Trial 20962","volume":"21","author":"Poortmans","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2024.11.088_bib0004","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1093\/neuonc\/nor186","article-title":"Cognitive functions in primary CNS lymphoma after single or combined modality regimens","volume":"14","author":"Correa","year":"2012","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.ijrobp.2024.11.088_bib0005","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1016\/S1470-2045(10)70229-1","article-title":"High-dose methotrexate with or without whole brain radiotherapy for primary CNS lymphoma (G-PCNSL-SG-1): A phase 3, randomised, non-inferiority trial","volume":"11","author":"Thiel","year":"2010","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ijrobp.2024.11.088_bib0006","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1093\/annonc\/mdl464","article-title":"Cognitive functions in primary central nervous system lymphoma: Literature review and assessment guidelines","volume":"18","author":"Correa","year":"2007","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ijrobp.2024.11.088_bib0007","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1212\/WNL.62.4.532","article-title":"Neurocognitive outcomes in primary CNS lymphoma (PCNSL)","volume":"62","author":"O'Neill","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.ijrobp.2024.11.088_bib0008","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.cell.2018.10.049","article-title":"Methotrexate chemotherapy induces persistent tri-glial dysregulation that underlies chemotherapy-related cognitive impairment","volume":"176","author":"Gibson","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.ijrobp.2024.11.088_bib0009","doi-asserted-by":"crossref","first-page":"292","DOI":"10.4103\/0973-1482.98993","article-title":"Methotrexate-induced acute toxic leukoencephalopathy","volume":"8","author":"Salkade","year":"2012","journal-title":"J Cancer Res Ther"},{"key":"10.1016\/j.ijrobp.2024.11.088_bib0010","doi-asserted-by":"crossref","first-page":"e510","DOI":"10.1016\/S2352-3026(17)30174-6","volume":"4","author":"Ferreri","year":"2017","journal-title":"Lancet Haematol"},{"key":"10.1016\/j.ijrobp.2024.11.088_bib0011","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1093\/neuonc\/noab021","article-title":"Neurocognitive functioning and radiologic changes in primary CNS lymphoma patients: Results from the HOVON 105\/ALLG NHL 24 randomized controlled trial","volume":"23","author":"van der Meulen","year":"2021","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.ijrobp.2024.11.088_bib0012","doi-asserted-by":"crossref","first-page":"3692","DOI":"10.1200\/JCO.22.00491","article-title":"Radiotherapy or autologous stem-cell transplantation for primary CNS lymphoma in patients age 60 years and younger: Long-term results of the randomized phase II PRECIS Study","volume":"40","author":"Houillier","year":"2022","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2024.11.088_bib0013","first-page":"2501","article-title":"Randomized phase ii study of rituximab, methotrexate (MTX), procarbazine, vincristine, and cytarabine (R-MPV-A) with and without low-dose whole-brain radiotherapy (LD-WBRT) for newly diagnosed primary CNS lymphoma (PCNSL)","volume":"38","author":"Omuro","year":"2020","journal-title":"ASCO Conf"},{"key":"10.1016\/j.ijrobp.2024.11.088_bib0014","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1007\/s11060-019-03257-1","article-title":"Longitudinal cognitive assessment in patients with primary CNS lymphoma treated with induction chemotherapy followed by reduced-dose whole-brain radiotherapy or autologous stem cell transplantation","volume":"144","author":"Correa","year":"2019","journal-title":"J Neurooncol"},{"key":"10.1016\/j.ijrobp.2024.11.088_bib0015","doi-asserted-by":"crossref","first-page":"3444","DOI":"10.1200\/JCO.2013.51.7557","article-title":"Ten years of international primary CNS lymphoma collaborative group studies","volume":"31","author":"Ferreri","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2024.11.088_bib0016","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1212\/WNL.44.9.1660","article-title":"Volumetric MRI analysis of the amygdala and the hippocampus in subjects with age-associated memory impairment: Correlation to visual and verbal memory","volume":"44","author":"Soininen","year":"1994","journal-title":"Neurology"},{"key":"10.1016\/j.ijrobp.2024.11.088_bib0017","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/S0140-6736(96)05228-2","article-title":"Visualisation and quantification of rates of atrophy in Alzheimer's disease","volume":"348","author":"Fox","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.ijrobp.2024.11.088_bib0018","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/S0140-6736(04)15441-X","article-title":"Imaging cerebral atrophy: Normal ageing to Alzheimer's disease","volume":"363","author":"Fox","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.ijrobp.2024.11.088_bib0019","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/S0140-6736(03)14469-8","article-title":"Change in rates of cerebral atrophy over time in early-onset Alzheimer's disease: Longitudinal MRI study","volume":"362","author":"Chan","year":"2003","journal-title":"Lancet"},{"issue":"3, pt 1","key":"10.1016\/j.ijrobp.2024.11.088_bib0020","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1212\/WNL.42.3.527","article-title":"Quantitative cerebral anatomy of the aging human brain: A cross-sectional study using magnetic resonance imaging","volume":"42","author":"Coffey","year":"1992","journal-title":"Neurology"},{"key":"10.1016\/j.ijrobp.2024.11.088_bib0021","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1212\/01.WNL.0000154530.72969.11","article-title":"Normative estimates of cross-sectional and longitudinal brain volume decline in aging and AD","volume":"64","author":"Fotenos","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.ijrobp.2024.11.088_bib0022","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.18153","article-title":"Characterization of brain volume changes in aging individuals with normal cognition using serial magnetic resonance imaging","volume":"6","author":"Fujita","year":"2023","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.ijrobp.2024.11.088_bib0023","doi-asserted-by":"crossref","first-page":"5034","DOI":"10.1200\/JCO.2005.13.524","article-title":"Report of an international workshop to standardize baseline evaluation and response criteria for primary CNS lymphoma","volume":"23","author":"Abrey","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2024.11.088_bib0024","doi-asserted-by":"crossref","first-page":"5711","DOI":"10.1200\/JCO.2006.08.2941","article-title":"Primary central nervous system lymphoma: the Memorial Sloan-Kettering Cancer Center prognostic model","volume":"24","author":"Abrey","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2024.11.088_bib0025","doi-asserted-by":"crossref","first-page":"6195","DOI":"10.1182\/bloodadvances.2024013780","article-title":"Evolving consolidation patterns and outcomes for a large cohort of patients with primary CNS lymphoma","volume":"8","author":"Tringale","year":"2024","journal-title":"Blood Adv"},{"key":"10.1016\/j.ijrobp.2024.11.088_bib0026","doi-asserted-by":"crossref","first-page":"e217","DOI":"10.1016\/S2352-3026(16)00036-3","article-title":"Chemoimmunotherapy with methotrexate, cytarabine, thiotepa, and rituximab (MATRix regimen) in patients with primary CNS lymphoma: Results of the first randomisation of the International Extranodal Lymphoma Study Group-32 (IELSG32) phase 2 trial","volume":"3","author":"Ferreri","year":"2016","journal-title":"Lancet Haematol"},{"key":"10.1016\/j.ijrobp.2024.11.088_bib0027","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/S1470-2045(18)30747-2","article-title":"Rituximab in patients with primary CNS lymphoma (HOVON 105\/ALLG NHL 24): A randomised, open-label, phase 3 intergroup study","volume":"20","author":"Bromberg","year":"2019","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ijrobp.2024.11.088_bib0028","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.ijrobp.2016.10.035","article-title":"Radiation dose\u2013dependent hippocampal atrophy detected with longitudinal volumetric magnetic resonance imaging","volume":"97","author":"Seibert","year":"2017","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2024.11.088_bib0029","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.ijrobp.2015.10.026","article-title":"Dose-dependent cortical thinning after partial brain irradiation in high-grade glioma","volume":"94","author":"Karunamuni","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2024.11.088_bib0030","doi-asserted-by":"crossref","first-page":"S101","DOI":"10.1016\/j.ijrobp.2017.06.241","article-title":"Prospective trial of quantitative neuroimaging correlates of verbal and nonverbal memory decline","volume":"99","author":"Tringale","year":"2017","journal-title":"Int J Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2024.11.088_bib0031","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.radonc.2018.11.018","article-title":"Identifying early diffusion imaging biomarkers of regional white matter injury as indicators of executive function decline following brain radiotherapy: A prospective clinical trial in primary brain tumor patients","volume":"132","author":"Tringale","year":"2019","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2024.11.088_bib0032","doi-asserted-by":"crossref","first-page":"12822","DOI":"10.1073\/pnas.1307301110","article-title":"Cranial irradiation compromises neuronal architecture in the hippocampus","volume":"110","author":"Parihar","year":"2013","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.ijrobp.2024.11.088_bib0033","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.brachy.2012.04.002","article-title":"Brachytherapy provides comparable outcomes and improved cost-effectiveness in the treatment of low\/intermediate prostate cancer","volume":"11","author":"Shah","year":"2012","journal-title":"Brachytherapy"},{"key":"10.1016\/j.ijrobp.2024.11.088_bib0034","doi-asserted-by":"crossref","first-page":"209","DOI":"10.2307\/3577608","article-title":"Time- and dose-dependent changes in neuronal activity produced by X radiation in brain slices","volume":"122","author":"Pellmar","year":"1990","journal-title":"Radiat Res"},{"key":"10.1016\/j.ijrobp.2024.11.088_bib0035","doi-asserted-by":"crossref","first-page":"3971","DOI":"10.1200\/JCO.2013.50.4910","article-title":"Rituximab, methotrexate, procarbazine, and vincristine followed by consolidation reduced-dose whole-brain radiotherapy and cytarabine in newly diagnosed primary CNS lymphoma: Final results and long-term outcome","volume":"31","author":"Morris","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2024.11.088_bib0036","doi-asserted-by":"crossref","first-page":"35","DOI":"10.3857\/roj.2020.00052","article-title":"Reduced-dose whole-brain radiotherapy with tumor bed boost after upfront high-dose methotrexate for primary central nervous system lymphoma","volume":"38","author":"Lee","year":"2020","journal-title":"Radiat Oncol J"},{"key":"10.1016\/j.ijrobp.2024.11.088_bib0037","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1212\/WNL.0b013e318297eeba","article-title":"Long-term cognitive function, neuroimaging, and quality of life in primary CNS lymphoma","volume":"81","author":"Doolittle","year":"2013","journal-title":"Neurology"},{"key":"10.1016\/j.ijrobp.2024.11.088_bib0038","doi-asserted-by":"crossref","first-page":"e28005","DOI":"10.1002\/pbc.28005","article-title":"The relationship between ventricular volume and whole-brain irradiation dose in central nervous system germ cell tumors","volume":"66","author":"Toll","year":"2019","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.ijrobp.2024.11.088_bib0039","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s11548-014-1128-3","article-title":"Morphometry-based measurements of the structural response to whole-brain radiation","volume":"10","author":"Fuentes","year":"2015","journal-title":"Int J Comput Assist Radiol Surg"},{"key":"10.1016\/j.ijrobp.2024.11.088_bib0040","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1093\/neuonc\/nox150","article-title":"Brain volume reduction after whole-brain radiotherapy: Quantification and prognostic relevance","volume":"20","author":"Hoffmann","year":"2018","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.ijrobp.2024.11.088_bib0041","doi-asserted-by":"crossref","first-page":"261","DOI":"10.3171\/jns.2000.92.2.0261","article-title":"Primary intracerebral malignant lymphoma: Report of 248 cases","volume":"92","author":"Bataille","year":"2000","journal-title":"J Neurosurg"},{"key":"10.1016\/j.ijrobp.2024.11.088_bib0042","first-page":"490","article-title":"Cognitive functions in primary central nervous system lymphoma patients treated with chemotherapy and stem cell transplantation: Preliminary findings","volume":"1","author":"Correa","year":"2003","journal-title":"Clin Adv Hematol Oncol"},{"key":"10.1016\/j.ijrobp.2024.11.088_bib0043","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1001\/archneur.60.4.563","article-title":"Cognitive performance and magnetic resonance imaging findings after high-dose systemic and intraventricular chemotherapy for primary central nervous system lymphoma","volume":"60","author":"Fliessbach","year":"2003","journal-title":"Arch Neurol"},{"key":"10.1016\/j.ijrobp.2024.11.088_bib0044","doi-asserted-by":"crossref","first-page":"3000","DOI":"10.1200\/JCO.1998.16.9.3000","article-title":"Phase II trial of chemotherapy alone for primary CNS and intraocular lymphoma","volume":"16","author":"Sandor","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2024.11.088_bib0045","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1002\/ana.20495","article-title":"NOA-3 trial of high-dose methotrexate in primary central nervous system lymphoma: Final report","volume":"57","author":"Herrlinger","year":"2005","journal-title":"Ann Neurol"},{"key":"10.1016\/j.ijrobp.2024.11.088_bib0046","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/s11060-019-03279-9","article-title":"White matter changes in primary central nervous system lymphoma patients treated with high-dose methotrexate with or without rituximab","volume":"145","author":"Estephan","year":"2019","journal-title":"J Neurooncol"},{"key":"10.1016\/j.ijrobp.2024.11.088_bib0047","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1212\/01.WNL.0000109673.75316.D8","article-title":"Cognitive functions in survivors of primary central nervous system lymphoma","volume":"62","author":"Correa","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.ijrobp.2024.11.088_bib0048","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1007\/s11682-023-00804-3","article-title":"Hippocampal subfield volumes in mild cognitive impairment and alzheimer's disease: A systematic review and meta-analysis","volume":"17","author":"Zhang","year":"2023","journal-title":"Brain Imaging Behav"},{"key":"10.1016\/j.ijrobp.2024.11.088_bib0049","doi-asserted-by":"crossref","first-page":"781","DOI":"10.4093\/dmj.2021.0189","article-title":"Association between type 2 diabetes mellitus and brain atrophy: A meta-analysis","volume":"46","author":"Zhang","year":"2022","journal-title":"Diabetes Metab J"},{"key":"10.1016\/j.ijrobp.2024.11.088_bib0050","doi-asserted-by":"crossref","first-page":"e2114","DOI":"10.1212\/WNL.0000000000207156","article-title":"Accelerated brain volume loss caused by anti-\u03b2-amyloid drugs: A systematic review and meta-analysis","volume":"100","author":"Alves","year":"2023","journal-title":"Neurology"},{"key":"10.1016\/j.ijrobp.2024.11.088_bib0051","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1093\/neuonc\/noae115","article-title":"Outcomes and relapse patterns in primary central nervous system lymphoma: Longitudinal analysis of 559 patients diagnosed from 1983 to 2020","volume":"26","author":"Tringale","year":"2024","journal-title":"Neuro Oncol"}],"container-title":["International Journal of Radiation Oncology*Biology*Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301624036617?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301624036617?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T22:52:11Z","timestamp":1762296731000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0360301624036617"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":51,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["S0360301624036617"],"URL":"https:\/\/doi.org\/10.1016\/j.ijrobp.2024.11.088","relation":{},"ISSN":["0360-3016"],"issn-type":[{"value":"0360-3016","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Consolidation Regimen and Cerebral Atrophy in Patients With Primary Central Nervous System Lymphoma","name":"articletitle","label":"Article Title"},{"value":"International Journal of Radiation Oncology*Biology*Physics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijrobp.2024.11.088","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}